Browse public CME signals with their source context and measured market impact. Open any signal for its permanent analysis page.
CME Group is set to report Q3 earnings before the open on Oct 21, with expected EPS of $2.98 on $1.71B in revenue. International average daily volume rose 22% to 9 million contracts in Q3, underscoring stronger activity outside the U.S. While price targets among analysts vary (roughly $270–$337), a beat or strong guidance could spark a near-term upside for CME stock, given the volume momentum and cash-flow implications of higher global activity.
View signal analysis →CME Group announced new futures contracts for Bitcoin Cash and Uniswap, expanding its regulated crypto derivatives menu. The move follows growing institutional interest in altcoins, with CME's broader exposure potentially boosting volumes and fee revenue if adoption accelerates. Near term, BCH’s price spike and UNI’s breakout highlight active trading that could support CME’s top-line momentum, though stock reaction may remain muted until sustained flow materializes.
View signal analysis →CME Group reported a fresh FX futures and options open-interest record of 4.41 million contracts on Sept 4, 2026, with large holders totaling 1,446 and asset managers notional exceeding $200 billion. The surge signals stronger buy-side demand for centralized clearing and risk management, potentially boosting near-term clearing, data, and fee revenue across CME Globex, BrokerTec, and CME Clearing.
View signal analysis →CME Group topped Q2 profit estimates thanks to robust hedging demand, sending shares up 6.1%. The print underscores durable demand for risk-management products amid market volatility and could support a higher multiple if this trend continues into the next quarter. Investors will watch whether hedging revenue proves sticky and CME gains share of incremental derivative activity versus peers.
View signal analysis →CME Group will launch Treasury Link, linking CBOT Treasury futures with BrokerTec cash Treasuries in a single spread. The Q4 2026 rollout, pending regulatory approval, could lift volumes, reduce legging risk, and broaden fixed-income spread trading opportunities.
View signal analysis →As regulatory disputes intensify around prediction markets, CME Group's focus on non-sports event contracts may help mitigate risks. The surge in private company valuations indicates a robust market potential. CME's strategic positioning suggests it could capitalize on growing demand for forecasting across various sectors.
View signal analysis →
